STONE TRIAL |
|
|---|---|
| Problem | Hypertension, age 60-79 |
| Format | - |
| Treatment | Nifedipine |
| Control | Placebo |
| Population | 1632 |
| Inclusion criteria | - |
| Exclusion criteria | - |
| Follow-up | 36 months, mean 30 months |
| Primary endpoint | Stroke, severe arrhythmia |
| Secondary endpoint(s) | Blood pressure |
| Details | . |
| Brief summary: | |
| PAPER: Shanghai trial of nifedipine in the elderly (STONE). | |
|---|---|
| Date | 1 Oct 1996 |
| Journal | J Hypertens 1996;14:1237-45 |
| Information | -Significant reduction in strokes and severe arrhythmia -BP reduced for nifedipine and placebo, greater benefit from nifedipine -Increased benefit with longer treatment duration |